Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03600883 |
|---|---|
| Brief Title: | A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) |
| First Submitted : | June 26, 2018 |
| First Submitted that Met QC Criteria : | July 17, 2018 |
| First Posted : | July 26, 2018 |
| Last Update Submitted that Met QC Criteria : | February 22, 2024 |
| Last Update Posted : | February 26, 2024 |